cabozantinib,atezolizumab
exelixis,roche
['urothelial carcinoma', 'atezolizumab', 'cabozantinib', 'urothelial', 'cosmic-021']
 cabozantinib (c) in combination with atezolizumab (a) in urothelial carcinoma (uc): results from cohorts 3, 4, 5 of the cosmic-021 study #asco22 
#PsyOnc @CettroOncologia | Former Postdoc Fellow & Visiting Scholar @cityofhope | @IPOSPsychoOncol BOD 2021-2023 | #ASCO22 FCOI: https://t.co/wuOhYiJHBM